Richard Goldstein, MD
Colon & Rectal Surgery · Langhorne, PANPI 1417948431
Payments from drug & device makers
Across 42 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$324
- Braintree Laboratories, Inc.$236
- Merck$98
- Ferring Pharmaceuticals Inc.$85
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$70
- Shire North American Group Inc$28
- plus $112 from 6 others
What the payments were for
- Food & beverage$87792%
- Gifts$778%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $324 |
| Braintree Laboratories, Inc. | 9 | $236 |
| Merck | 7 | $98 |
| Ferring Pharmaceuticals Inc. | 5 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Shire North American Group Inc | 1 | $28 |
| BD | 1 | $24 |
| Coloplast | 1 | $23 |
| Davol Inc. | 1 | $23 |
| Avanos Medical | 1 | $17 |
| Acell, Inc. | 1 | $14 |
| Misonix Inc | 1 | $11 |
How this compares
$954 in reported general payments places this provider in the 30th percentile of 108 colon & rectal surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 42 | $15,676 |
| Mesalamine ErMesalamine | 19 | $4,401 |
| Balsalazide Disodium | 29 | $3,463 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $292 |
| Fluconazole | 17 | $158 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $95 |
| Metronidazole | 19 | $80 |
| Metoprolol Tartrate | 13 | $72 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $61 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Langhorne
- John MarksWynnewood$477K
- Bogdan ProtyniakWilkes-Barre$429K
- James McCormickMonroeville$372K
- Jeffrey ScowHershey$290K
- Joshua BleierPhiladelphia$151K
- Richard FortunatoPittsburgh$80K
- Najjia MahmoudPhiladelphia$63K
- Michael DeutschWest Reading$61K
- Juan PoggioPhiladelphia$49K
- Gerald IsenbergPhiladelphia$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.